Predicting Hosts Based on Early SARS-Cov-2 Samples And
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Searching for Relatives of SARS-Cov-2 in Bats
RESEARCH HIGHLIGHTS IN BRIEF PUBLIC HEALTH Defeating dengue with Wolbachia The introduction of Wolbachia bacteria into Aedes aegypti mos- quitoes confers resistance to dengue virus (DENV) and other BROOK/ ROBERT Credit: LIBRARY/Alamy PHOTO SCIENCE arbovirues, and the release of Wolbachia- infected mosquitoes SYNTHETIC BIOLOGY in endemic regions may be an effective arboviral control strat- egy. Now, Utarini et al. report the results a cluster-randomized trial involving the release of A. aegypti mosquitoes infected with the wMel strain of Wolbachia pipientis for the control of DENV Designer bacteria infections in Yogyakarta, Indonesia. Geographical clusters ran- domly received either deployments of wMel- infected A. aegypti (interventional clusters) or no deployments (control clusters), Engineering bacteria by removing code of viral genomes. Cells were and virologically confirmed dengue (VCD) was surveyed in sense codons and their cognate treated with a cocktail of phages 8,144 patients from 18 primary care clinics. In the control clus- tRNAs could lead to the creation containing the phages lambda, ters, VCD occurred in 9.4% of patients but remarkably DENV of cells with desirable properties P1vir, T4, T6 and T7, which have was detected in only 2.3% of patients in interventional clusters. for biotechnology applications, such TCA or TCG sense codons that are The incidence of symptomatic dengue fever and hospitaliza- tions for VCD was significantly reduced in interventional clus- as complete resistance to contami- 10–58 times more abundant than the ters, suggesting that mosquito deployments could eliminate nating phages or the ability to incor- TAG codon in their genomes, and Ser dengue fever in endemic regions. -
The Rhinolophus Affinis Bat ACE2 and Multiple Animal Orthologs Are Functional 2 Receptors for Bat Coronavirus Ratg13 and SARS-Cov-2 3
bioRxiv preprint doi: https://doi.org/10.1101/2020.11.16.385849; this version posted November 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 The Rhinolophus affinis bat ACE2 and multiple animal orthologs are functional 2 receptors for bat coronavirus RaTG13 and SARS-CoV-2 3 4 Pei Li1#, Ruixuan Guo1#, Yan Liu1#, Yintgtao Zhang2#, Jiaxin Hu1, Xiuyuan Ou1, Dan 5 Mi1, Ting Chen1, Zhixia Mu1, Yelin Han1, Zhewei Cui1, Leiliang Zhang3, Xinquan 6 Wang4, Zhiqiang Wu1*, Jianwei Wang1*, Qi Jin1*,, Zhaohui Qian1* 7 NHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen 8 Biology, Chinese Academy of Medical Sciences and Peking Union Medical College1, 9 Beijing, 100176, China; School of Pharmaceutical Sciences, Peking University2, 10 Beijing, China; .Institute of Basic Medicine3, Shandong First Medical University & 11 Shandong Academy of Medical Sciences, Jinan 250062, Shandong, China; The 12 Ministry of Education Key Laboratory of Protein Science, Beijing Advanced 13 Innovation Center for Structural Biology, Beijing Frontier Research Center for 14 Biological Structure, Collaborative Innovation Center for Biotherapy, School of Life 15 Sciences, Tsinghua University4, Beijing, China; 16 17 Keywords: SARS-CoV-2, bat coronavirus RaTG13, spike protein, Rhinolophus affinis 18 bat ACE2, host susceptibility, coronavirus entry 19 20 #These authors contributed equally to this work. 21 *To whom correspondence should be addressed: [email protected], 22 [email protected], [email protected], [email protected] 23 bioRxiv preprint doi: https://doi.org/10.1101/2020.11.16.385849; this version posted November 17, 2020. -
On the Coronaviruses and Their Associations with the Aquatic Environment and Wastewater
water Review On the Coronaviruses and Their Associations with the Aquatic Environment and Wastewater Adrian Wartecki 1 and Piotr Rzymski 2,* 1 Faculty of Medicine, Poznan University of Medical Sciences, 60-812 Pozna´n,Poland; [email protected] 2 Department of Environmental Medicine, Poznan University of Medical Sciences, 60-806 Pozna´n,Poland * Correspondence: [email protected] Received: 24 April 2020; Accepted: 2 June 2020; Published: 4 June 2020 Abstract: The outbreak of Coronavirus Disease 2019 (COVID-19), a severe respiratory disease caused by betacoronavirus SARS-CoV-2, in 2019 that further developed into a pandemic has received an unprecedented response from the scientific community and sparked a general research interest into the biology and ecology of Coronaviridae, a family of positive-sense single-stranded RNA viruses. Aquatic environments, lakes, rivers and ponds, are important habitats for bats and birds, which are hosts for various coronavirus species and strains and which shed viral particles in their feces. It is therefore of high interest to fully explore the role that aquatic environments may play in coronavirus spread, including cross-species transmissions. Besides the respiratory tract, coronaviruses pathogenic to humans can also infect the digestive system and be subsequently defecated. Considering this, it is pivotal to understand whether wastewater can play a role in their dissemination, particularly in areas with poor sanitation. This review provides an overview of the taxonomy, molecular biology, natural reservoirs and pathogenicity of coronaviruses; outlines their potential to survive in aquatic environments and wastewater; and demonstrates their association with aquatic biota, mainly waterfowl. It also calls for further, interdisciplinary research in the field of aquatic virology to explore the potential hotspots of coronaviruses in the aquatic environment and the routes through which they may enter it. -
Hydroxychloroquine Or Chloroquine for Treating Coronavirus Disease 2019 (COVID-19) – a PROTOCOL for a Systematic Review of Individual Participant Data
Hydroxychloroquine or Chloroquine for treating Coronavirus Disease 2019 (COVID-19) – a PROTOCOL for a systematic review of Individual Participant Data Authors Fontes LE, Riera R, Miranda E, Oke J, Heneghan CJ, Aronson JK, Pacheco RL, Martimbianco ALC, Nunan D BACKGROUND In the face of the pandemic of SARS CoV2, urgent research is needed to test potential therapeutic agents against the disease. Reliable research shall inform clinical decision makers. Currently, there are several studies testing the efficacy and safety profiles of different pharmacological interventions. Among these drugs, we can cite antimalarial, antivirals, biological drugs, interferon, etc. As of 6 April 2020 there are three published reportsand 100 ongoing trials testing hydroxychloroquine/chloroquine alone or in association with other drugs for COVID-19. This prospective systematic review with Individual Participant data aims to assess the rigour of the best-available evidence for hydroxychloroquine or chloroquine as treatment for COVID-19 infection. The PICO framework is: P: adults with COVID-19 infection I: chloroquine or hydroxychloroquine (alone or in association) C: placebo, other active treatments, usual standard care without antimalarials O: efficacy and safety outcomes OBJECTIVES To assess the effects (benefits and harms) of chloroquine or hydroxychloroquine for the treatment of COVID-19 infection. METHODS Criteria for considering studies for this review Types of studies We shall include randomized controlled trials (RCTs) with a parallel design. We intend to include even small trials (<50 participants), facing the urgent need for evidence to respond to the current pandemic. Quasi-randomized, non-randomized, or observational studies will be excluded due to a higher risk of confounding and selection bias (1). -
Immune Evasion of SARS-Cov-2 Emerging Variants: What Have We Learnt So Far?
viruses Review Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far? Ivana Lazarevic * , Vera Pravica, Danijela Miljanovic and Maja Cupic Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia; [email protected] (V.P.); [email protected] (D.M.); [email protected] (M.C.) * Correspondence: [email protected]; Tel.: +381-11-3643-379 Abstract: Despite the slow evolutionary rate of SARS-CoV-2 relative to other RNA viruses, its massive and rapid transmission during the COVID-19 pandemic has enabled it to acquire significant genetic diversity since it first entered the human population. This led to the emergence of numerous variants, some of them recently being labeled “variants of concern” (VOC), due to their potential impact on transmission, morbidity/mortality, and the evasion of neutralization by antibodies elicited by infection, vaccination, or therapeutic application. The potential to evade neutralization is the result of diversity of the target epitopes generated by the accumulation of mutations in the spike protein. While three globally recognized VOCs (Alpha or B.1.1.7, Beta or B.1.351, and Gamma or P.1) remain sensitive to neutralization albeit at reduced levels by the sera of convalescent individuals and recipients of several anti-COVID19 vaccines, the effect of spike variability is much more evident on the neutralization capacity of monoclonal antibodies. The newly recognized VOC Delta or lineage B.1.617.2, as well as locally accepted VOCs (Epsilon or B.1.427/29-US and B1.1.7 with the E484K-UK) are indicating the necessity of close monitoring of new variants on a global level. -
Complete Sections As Applicable
This form should be used for all taxonomic proposals. Please complete all those modules that are applicable (and then delete the unwanted sections). For guidance, see the notes written in blue and the separate document “Help with completing a taxonomic proposal” Please try to keep related proposals within a single document; you can copy the modules to create more than one genus within a new family, for example. MODULE 1: TITLE, AUTHORS, etc (to be completed by ICTV Code assigned: 2010.023a-dV officers) Short title: A new genus and three new species in the subfamily Coronavirinae (e.g. 6 new species in the genus Zetavirus) Modules attached 1 2 3 4 5 (modules 1 and 9 are required) 6 7 8 9 Author(s) with e-mail address(es) of the proposer: Raoul J. de Groot and Alexander E. Gorbalenya List the ICTV study group(s) that have seen this proposal: A list of study groups and contacts is provided at http://www.ictvonline.org/subcommittees.asp . If Submission on behalf of the Coronavirus Study in doubt, contact the appropriate subcommittee Group. Authors are CSG members (R.J de chair (fungal, invertebrate, plant, prokaryote or Groot, Chair) vertebrate viruses) ICTV-EC or Study Group comments and response of the proposer: Date first submitted to ICTV: Date of this revision (if different to above): Page 1 of 5 MODULE 2: NEW SPECIES Code 2010.023aV (assigned by ICTV officers) To create new species within: Genus: Deltacoronavirus (new) Subfamily: Coronavirinae Family: Coronaviridae Order: Nidovirales And name the new species: GenBank sequence accession number(s) of reference isolate: Bulbul coronavirus HKU11 [FJ376619] Thrush coronavirus HKU12 [FJ376621=NC_011549] Munia coronavirus HKU13 [FJ376622=NC_011550] Reasons to justify the creation and assignment of the new species: According to the demarcation criteria as outlined in Module 3 and agreed upon by the Coronavirus Study Group, the new coronaviruses isolated from Bulbul, Thrush and Munia are representatives of separates species. -
The COVID-19 Pandemic: a Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control
Journal of Clinical Medicine Review The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control Yosra A. Helmy 1,2,* , Mohamed Fawzy 3,*, Ahmed Elaswad 4, Ahmed Sobieh 5, Scott P. Kenney 1 and Awad A. Shehata 6,7 1 Department of Veterinary Preventive Medicine, Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, OH 44691, USA; [email protected] 2 Department of Animal Hygiene, Zoonoses and Animal Ethology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt 3 Department of Virology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt 4 Department of Animal Wealth Development, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt; [email protected] 5 Department of Radiology, University of Massachusetts Medical School, Worcester, MA 01655, USA; [email protected] 6 Avian and Rabbit Diseases Department, Faculty of Veterinary Medicine, Sadat City University, Sadat 32897, Egypt; [email protected] 7 Research and Development Section, PerNaturam GmbH, 56290 Gödenroth, Germany * Correspondence: [email protected] (Y.A.H.); [email protected] (M.F.) Received: 18 March 2020; Accepted: 21 April 2020; Published: 24 April 2020 Abstract: A pneumonia outbreak with unknown etiology was reported in Wuhan, Hubei province, China, in December 2019, associated with the Huanan Seafood Wholesale Market. The causative agent of the outbreak was identified by the WHO as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), producing the disease named coronavirus disease-2019 (COVID-19). The virus is closely related (96.3%) to bat coronavirus RaTG13, based on phylogenetic analysis. -
WHO-Convened Global Study of Origins of SARS-Cov-2: China Part
WHO-convened Global Study of Origins of SARS-CoV-2: China Part Joint WHO-China Study 14 January-10 February 2021 Joint Report 1 LIST OF ABBREVIATIONS AND ACRONYMS ARI acute respiratory illness cDNA complementary DNA China CDC Chinese Center for Disease Control and Prevention CNCB China National Center for Bioinformation CoV coronavirus Ct values cycle threshold values DDBJ DNA Database of Japan EMBL-EBI European Molecular Biology Laboratory and European Bioinformatics Institute FAO Food and Agriculture Organization of the United Nations GISAID Global Initiative on Sharing Avian Influenza Database GOARN Global Outbreak Alert and Response Network Hong Kong SAR Hong Kong Special Administrative Region Huanan market Huanan Seafood Wholesale Market IHR International Health Regulations (2005) ILI influenza-like illness INSD International Nucleotide Sequence Database MERS Middle East respiratory syndrome MRCA most recent common ancestor NAT nucleic acid testing NCBI National Center for Biotechnology Information NMDC National Microbiology Data Center NNDRS National Notifiable Disease Reporting System OIE World Organisation for Animal Health (Office international des Epizooties) PCR polymerase chain reaction PHEIC public health emergency of international concern RT-PCR real-time polymerase chain reaction SARI severe acute respiratory illness SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 SARSr-CoV-2 Severe acute respiratory syndrome coronavirus 2-related virus tMRCA time to most recent common ancestor WHO World Health Organization WIV Wuhan Institute of Virology 2 Acknowledgements WHO gratefully acknowledges the work of the joint team, including Chinese and international scientists and WHO experts who worked on the technical sections of this report, and those who worked on studies to prepare data and information for the joint mission. -
Identification of a SARS- Like Bat Coronavirus That Shares Structural
SHORT COMMUNICATION Fraguas Bringas and Booth, Access Microbiology 2020;2 DOI 10.1099/acmi.0.000166 OPEN ACCESS Identification of a SARS- like bat coronavirus that shares structural features with the spike glycoprotein receptor- binding domain of SARS- CoV-2 Conchita Fraguas Bringas and David Booth* Abstract SARS- CoV-2 is a recently emerged coronavirus that binds angiotensin- converting enzyme 2 (ACE2) for cell entry via its receptor- binding domain (RBD) on a surface- expressed spike glycoprotein. Studies show that despite its similarities to severe acute respiratory syndrome (SARS) coronavirus, there are critical differences in key RBD residues when compared to SARS- CoV-2. Here we present a short in silico study, showing that SARS- like bat coronavirus Rs3367 shares a high conservation with SARS- CoV-2 in important RBD residues for ACE2 binding: SARS- CoV-2’s Phe486, Thr500, Asn501 and Tyr505; implicated in receptor- binding strength and host-range determination. These features were not shared with other studied bat coronavi- ruses belonging to the betacoronavirus genus, including RaTG13, the closest reported bat coronavirus to SARS- CoV-2’s spike protein. Sequence and phylogeny analyses were followed by the computation of a reliable model of the RBD of SARS- like bat coronavirus Rs3367, which allowed structural insight of the conserved residues. Superimposition of this model on the SARS- CoV-2 ACE2- RBD complex revealed critical ACE2 contacts are also maintained. In addition, residue Asn488Rs3367 interacted with a previously defined pocket on ACE2 composed of Tyr41, Lys353 and Asp355. When compared to available SARS-CoV-2 crystal structure data, Asn501SARS- CoV-2 showed a different interaction with the ACE2 pocket. -
Spike Mutation T403R Allows Bat Coronavirus Ratg13 to Use Human
bioRxiv preprint doi: https://doi.org/10.1101/2021.05.31.446386; this version posted May 31, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Spike mutation T403R allows bat coronavirus 2 RaTG13 to use human ACE2 3 Fabian Zech1, Daniel Schniertshauer1, Christoph Jung2,3,4, Alexandra Herrmann5, Qinya 4 Xie1, Rayhane Nchioua1, Caterina Prelli Bozzo1, Meta Volcic1, Lennart Koepke1, Jana 5 Krüger6, Sandra Heller6, Alexander Kleger6, Timo Jacob2,3,4, Karl-Klaus Conzelmann7, 6 Armin Ensser5, Konstantin M.J. Sparrer1 and Frank Kirchhoff1* 7 8 1Institute of Molecular Virology, Ulm University Medical Center, 89081 Ulm, Germany; 9 2Institute of Electrochemistry, Ulm University, 89081 Ulm, Germany; 3Helmholtz-Institute 10 Ulm (HIU) Electrochemical Energy Storage, Helmholtz-Straße 16, 89081 Ulm, Germany; 11 4Karlsruhe Institute of Technology (KIT), P.O. Box 3640, 76021 Karlsruhe, Germany; 12 5Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich- 13 Alexander Universität Erlangen-Nürnberg, 91054 Erlangen, Germany. 6Department of 14 Internal Medicine I, Ulm University Medical Center, 89081 Ulm, Germany; 7Max von 15 Pettenkofer-Institute of Virology, Medical Faculty, and Gene Center, Ludwig-Maximilians- 16 Universität München, 81377 Munich, Germany. 17 18 * Address Correspondence to: [email protected] 19 20 Running title: T403R allows RaTG13 Spike to use human ACE2 21 22 KEYWORDS: SARS-CoV-2, RaTG13, spike glycoprotein, ACE2 receptor, viral zoonosis 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.05.31.446386; this version posted May 31, 2021. -
Coronaviruses in Avian Species – Review with Focus on Epidemiology and Diagnosis in Wild Birds
J Vet Res 62, 249-255, 2018 DOI:10.2478/jvetres-2018-0035 REVIEW ARTICLE Coronaviruses in avian species – review with focus on epidemiology and diagnosis in wild birds Justyna Miłek, Katarzyna Blicharz-Domańska Department of Poultry Diseases, National Veterinary Research Institute, 24-100 Puławy, Poland [email protected] Received: May 2, 2018 Accepted: September 19, 2018 Abstract Coronaviruses (CoVs) are a large group of enveloped viruses with a single-strand RNA genome, which continuously circulate in mammals and birds and pose a threat to livestock, companion animals, and humans. CoVs harboured by avian species are classified to the genera gamma- and deltacoronaviruses. Within the gamma-CoVs the main representative is avian coronavirus, a taxonomic name which includes the highly contagious infectious bronchitis viruses (IBVs) in chickens and similar viruses infecting other domestic birds such as turkeys, guinea fowls, or quails. Additionally, IBVs have been detected in healthy wild birds, demonstrating that they may act as the vector between domestic and free-living birds. Moreover, CoVs other than IBVs, are identified in wild birds, which suggests that wild birds play a key role in the epidemiology of other gammaCoVs and deltaCoVs. Development of molecular techniques has significantly improved knowledge of the prevalence of CoVs in avian species. The methods adopted in monitoring studies of CoVs in different avian species are mainly based on detection of conservative regions within the viral replicase, nucleocapsid genes, and 3’UTR or 5’UTR. The purpose of this review is to summarise recent discoveries in the areas of epidemiology and diagnosis of CoVs in avian species and to understand the role of wild birds in the virus distribution. -
Occurrence and Sequence Analysis of Porcine Deltacoronaviruses In
Zhai et al. Virology Journal (2016) 13:136 DOI 10.1186/s12985-016-0591-6 RESEARCH Open Access Occurrence and sequence analysis of porcine deltacoronaviruses in southern China Shao-Lun Zhai1†, Wen-Kang Wei1†, Xiao-Peng Li1†, Xiao-Hui Wen1, Xia Zhou1, He Zhang1, Dian-Hong Lv1*, Feng Li2,3 and Dan Wang2* Abstract Background: Following the initial isolation of porcine deltacoronavirus (PDCoV) from pigs with diarrheal disease in the United States in 2014, the virus has been detected on swine farms in some provinces of China. To date, little is known about the molecular epidemiology of PDCoV in southern China where major swine production is operated. Results: To investigate the prevalence of PDCoV in this region and compare its activity to other enteric disease of swine caused by porcine epidemic diarrhea virus (PEDV), transmissible gastroenteritis coronavirus (TGEV), and porcine rotavirus group C (Rota C), 390 fecal samples were collected from swine of various ages from 15 swine farms with reported diarrhea. Fecal samples were tested by reverse transcription-PCR (RT-PCR) that targeted PDCoV, PEDV, TGEV, and Rota C, respectively. PDCoV was detected exclusively from nursing piglets with an overall prevalence of approximate 1.28 % (5/390), not in suckling and fattening piglets. Interestingly, all of PDCoV-positive samples were from 2015 rather than 2012–2014. Despite a low detection rate, PDCoV emerged in each province/region of southern China. In addition, compared to TGEV (1.54 %, 5/390) or Rota C (1.28 %, 6/390), there were highly detection rates of PEDV (22.6 %, 88/390) in those samples.